Avoid common mistakes on your manuscript.
1 Correction to: Drugs 2017;77(13):1481–6 https://doi.org/10.1007/s40265-017-0790-5
The article Delafloxacin: First Global Approval, written by Anthony Markham, was originally published Online First without open access. After publication in volume 77, issue 13, pages 1481–1486 Melinta Therapeutics, Inc. requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Melinta Therapeutics, Inc. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
About this article
Cite this article
Markham, A. Correction to: Delafloxacin: First Global Approval. Drugs 78, 1651 (2018). https://doi.org/10.1007/s40265-018-0990-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40265-018-0990-7